---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-018603"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2026-04-23T23:59:59+00:00"
generated_at: "2026-05-15T04:38:45.166988+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CEO sells 3.1M shares in underwritten secondary offering, company receives no proceeds

## Summary
- Selling stockholder CEO Yoshiyuki Aikawa offered 3,100,000 common shares; underwriters have 45-day option for additional 465,000 shares.
- Company did not sell any shares and received no proceeds from the offering.
- Underwriting agreement with Maxim Group LLC as representative filed as Exhibit 1.1.
- Offering closed on April 21, 2026.
- Shares registered on Form S-3 (File No. 333-292451) filed December 29, 2025.

## SEC filing metadata
- accession: 0001493152-26-018603
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2026-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000149315226018603/0001493152-26-018603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000149315226018603/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-018603
- JSON: https://secwatch.observer/filing/0001493152-26-018603.json
- Plain text: https://secwatch.observer/filing/0001493152-26-018603.txt

## Key facts
- Material Agreements
  SBC Medical Group Holdings Inc entered into Underwriting Agreement with Maxim Group LLC (effective 2026-04-19).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Maxim Group LLC
  - Effective: 2026-04-19
  source text: On April 19, 2026, SBC Medical Group Holdings Incorporated (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company, Dr. Yoshiyuki Aikawa, the Company’s CEO and Chairman of the board of directors, as selling stockholder (the “Selling Stockholder”) and Maxim Group LLC, as representative of the several underwriters named in Schedule 1 thereto (the “Underwriters”), relating to an underwritten offering of 3,100,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share, pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-292451), filed on December 29, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1930313/000149315226018603/0001493152-26-018603-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.